Loading...

Purified anti-mouse/human CD11b Antibody Purified anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
1-M1slash70_Purified_042706
C57BL/6 mouse bone marrow cells were stained with purified CD11b (clone M1/70) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by anti-rat IgG FITC (gated on total cells).
  • 1-M1slash70_Purified_042706
    C57BL/6 mouse bone marrow cells were stained with purified CD11b (clone M1/70) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by anti-rat IgG FITC (gated on total cells).
  • 2-M170_Pure_CD11b_Antibody_IHC_102418
    Fresh, frozen mouse spleen was stained with purified CD11b clone M1/70 conjugated and detected with a Cy5 CODEX™ oligonucleotide duplex (red). Samples were counterstained with TCR FITC (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Compare all formats
Cat # Size Price Quantity Check Availability Save
101201 50 µg DKK179
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101202 500 µg DKK678
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F, CyTOF® - Verified
IP, ICC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Peterson EJ, et al. 2019. Mol Syst Biol. 15:e8584. PubMed
  2. Axelrod HD, et al. 2019. Mol Cancer Res. 17:356. PubMed
  3. Tong CF, et al. 2018. Am J Physiol Cell Physiol. 315:C409. PubMed
  4. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  5. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  6. Taki M, et al. 2018. Nat Commun. 1.545138889. PubMed
  7. Vinaik R, et al. 2019. Am J Physiol Endocrinol Metab. 317:E751. PubMed
  8. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  9. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  10. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  11. Li F, et al. 2020. EMBO J. 39:e103205. PubMed
  12. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  13. Doll JR, et al. 2020. PLoS Pathog. 16:e1008296. PubMed
  14. Yu H, et al. 2020. Front Immunol. 11:1773. PubMed
  15. Cai S, et al. 2020. Sci Rep. 10:14249. PubMed
  16. Calcagno DM, et al. 2020. Sci Immunol. 5: . PubMed
  17. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  18. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  19. Moore J, et al. 2022. Cancer Res. 82:365. PubMed
  20. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  21. Xiong T, et al. 2022. Cancer Sci. 113:1955. PubMed
  22. Campisi L, et al. 2022. Nature. 606:945. PubMed
  23. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  24. Zhao J, et al. 2022. J Clin Invest. 132: . PubMed
  25. Gavish A, et al. 2023. iScience. 26:105826. PubMed
  26. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  27. Potempa M, et al. 2022. J Immunol. 208:1742. PubMed
  28. Shirai T, et al. 2022. Cancer Sci. 113:3710. PubMed
  29. Chen W, et al. 2023. JCI Insight. 8:. PubMed
  30. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  31. Kang YA, et al. 2023. J Exp Med. 220:. PubMed
  32. Diray-Arce J, et al. 2023. Cell Rep Med. 4:101079. PubMed
  33. Yonemitsu K, et al. 2022. Sci Rep. 12:12007. PubMed
  34. Pilling D, et al. 2022. Respir Res. 23:215. PubMed
  35. Bajaña S, et al. 2021. Front Immunol. 11:577718. PubMed
  36. Zhao J, et al. 2021. JCI Insight. 6:. PubMed
  37. Larson-Casey JL, et al. 2021. FASEB J. 35:e21675. PubMed
  38. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  39. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  40. Weidner H, et al. 2020. JCI Insight. 5:00. PubMed
  41. Kim D, et al. 2008. Blood. 112:1109. PubMed
  42. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  43. Chung MI, et al. 2018. Am J Respir Cell Mol Biol. 59:706. PubMed
  44. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  45. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  46. Shirakawa K, et al. 2017. PLoS One. 12:e0186303. PubMed
  47. Zhou LJ et al. 2019. Cell Rep. 27(13):3844-3859 . PubMed
  48. Bachran C, et al. 2017. Sci Rep.. 10.1038/s41598-017-17948-0. PubMed
  49. Wagner J et al. 2019. Cell. 177(5):1330-1345 . PubMed
  50. Peng J, et al. 2019. Mol Brain. 12:71. PubMed
  51. Ajona D, et al. 2017. Cancer Discov. 0.773611111. PubMed
  52. Goel S, et al. 2017. Nature. 548:471. PubMed
  53. Tang B, et al. 2019. Oncolytic Virother. 8:03. PubMed
  54. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  55. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  56. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  57. Leyva-Castillo JM, et al. 2020. Clin Immunol. 218:108511. PubMed
  58. Dertschnig S, et al. 2020. J Clin Invest. 130:1896. PubMed
  59. Dienz O, et al. 2020. J Immunol. 204:1521. PubMed
  60. Nguyen N, et al. 2022. iScience. 25:103679. PubMed
  61. Karhadkar TR, et al. 2021. J Pharmacol Exp Ther. 376:106. PubMed
  62. Rogic A, et al. 2021. Nat Commun. 12:6889. PubMed
  63. Chen L, et al. 2019. Nat Commun. 3.553472222. PubMed
  64. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  65. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  66. Dave K et al. 2017. eLife. 6 pii: e23382. PubMed
  67. Arimura K, et al. 2017. Mucosal Immunol. 1.08125. PubMed
  68. Liu T, et al. 2020. Sci Adv. 6:eaay1497. PubMed
  69. Peng J, et al. 2016. Nat Commun. 7:12029. PubMed
  70. Bredehöft J, et al. 2022. J Inflamm Res. 15:509. PubMed
  71. Tian D, et al. 2020. FASEB J. 34:3367. PubMed
  72. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  73. Lee JH, et al. 2022. iScience. 25:104166. PubMed
  74. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  75. Tal MC, et al. 2020. MBio. 11:00. PubMed
  76. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  77. Haney MS, et al. 2018. Nat Genet. 50:1716. PubMed
  78. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  79. Rissiek B, et al. 2017. Sci Rep. . 10.1038/s41598-017-16613-w. PubMed
  80. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  81. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  82. Yang C, et al. 2019. MBio. 10:e00595-19. PubMed
  83. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  84. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  85. Guiducci E, et al. 2018. Front Immunol. 1.467361111. PubMed
  86. Guo Y, et al. 2008. Blood. 112:480. PubMed
  87. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  88. Si Y, et al. 2020. Sci Adv. 6:eaaw7713. PubMed
  89. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  90. Matsuhira T, et al. 2021. Biochem Biophys Rep. 28:101118. PubMed
  91. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  92. Yan J, et al. 2020. Cancer Immunol Res. 8:356. PubMed
  93. Gomi M, et al. 2021. Mol Ther. 29:225. PubMed
  94. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
  95. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  96. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  97. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  98. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  99. Zhao L, et al. 2018. Nat Med. 24:1536. PubMed
  100. Manni M, et al. 2018. Nat Immunol. 1.074305556. PubMed
  101. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  102. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  103. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  104. Napimoga M, et al. 2008. J Immunol. 180:609. PubMed
  105. Francis M, et al. 2017. Toxicol Sci. 155(1):182-195. PubMed
  106. Lai JF, et al. 2020. J Allergy Clin Immunol. 146:1406. PubMed
  107. Vukman KV, et al. 2020. J Extracell Vesicles. 10:e12023. PubMed
  108. Jiang L, et al. 2022. Front Immunol. 12:730438. PubMed
  109. Sato Y, et al. 2021. BMC Cancer. 21:1222. PubMed
  110. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  111. Muraleedharan A, et al. 2021. Glia. 69:697. PubMed
  112. Bednarczyk M, et al. 2021. Int J Mol Sci. 22:. PubMed
  113. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  114. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  115. Hakamivala A, et al. 2020. Bioact Mater. 5:142. PubMed
  116. Zhong X, et al. 2020. Proc Natl Acad Sci U S A. 8563:117. PubMed
  117. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  118. Wei S, et al. 2019. Virulence. 0.588888889. PubMed
  119. Kapellos TS, et al. 2017. Mediators Inflamm. 2017:4315412. PubMed
  120. Umemoto T, et al. 2017. EMBO J. 36:2390. PubMed
  121. Kim SJ, et al. 2017. Nat Immunol. 18:1016. PubMed
  122. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  123. Wicki S, et al. 2018. Int J Mol Sci. 1.266666667. PubMed
  124. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  125. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  126. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  127. Paharik AE, et al. 2017. Cell Host Microbe. 22:746. PubMed
  128. Nascimento DC, et al. 2017. Nat Commun. 8:14919. PubMed
  129. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  130. Majer O, et al. 2019. Nature. 575:366. PubMed
  131. Coden ME, et al. 2020. J Immunol. 204:438. PubMed
  132. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  133. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  134. Manabe T, et al. 2021. J Neurochem. 159:525. PubMed
  135. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  136. Lim CS, et al. 2020. Front Immunol. 11:1186. PubMed
  137. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  138. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  139. You X, et al. 2022. Front Genet. 12:790990. PubMed
  140. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  141. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  142. Huang S, et al. 2020. Cell Rep. 33:108394. PubMed
  143. Daley D, et al. 2017. Nat Med. 23:556. PubMed
  144. Hsieh JY, et al. 2019. APL Bioeng. 3:016103. PubMed
  145. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  146. Madsen D, et al. 2017. Cell Rep.. 10.1016/j.celrep.2017.12.011. PubMed
  147. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  148. Yoon BH, et al. 2018. Mol Cells. 41:953. PubMed
  149. Hoffmann FM, et al. 2018. Front Immunol. 9:1046. PubMed
  150. Baumgartner C, et al. 2010. J Immunol. 184:573. PubMed
  151. Yi MH, et al. 2020. Brain Behav Immun. 92:78. PubMed
  152. Meyer-Lindemann U, et al. 2022. Front Immunol. 13:898690. PubMed
  153. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  154. Li J, et al. 2021. Front Immunol. 12:710406. PubMed
  155. Nguyen CH, et al. 2020. Biomedicines. 8:. PubMed
  156. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  157. Speir M, et al. 2020. Nat Immunol. 21:54. PubMed
  158. Kikuchi A, et al. 2020. Am J Pathol. 190:2080. PubMed
  159. Freeman SA, et al. 2020. Science. 367:301. PubMed
  160. Galbas T, et al. 2017. J Immunol. 198(2):852-861. PubMed
  161. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  162. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  163. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  164. Wang Y, et al. 2019. Biomed Res Int. 2019:5756189. PubMed
  165. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  166. Elgazar-Carmon V, et al. 2008. J Lipid Res. 49:1849. PubMed
  167. Ding L, et al. 2022. Nanoscale. . PubMed
  168. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  169. Vahsen BF, et al. 2022. Sci Rep. 12:12606. PubMed
  170. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  171. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  172. Wu W, et al. 2020. Brain Behav Immun. 89:245. PubMed
  173. Qiu Z, et al. 2022. Cancer Discov. 12:502. PubMed
  174. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  175. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  176. Takeuchi Y, et al. 2021. Sci Rep. 11:18679. PubMed
  177. Feng L, et al. 2019. Glia. 67:1434. PubMed
  178. Wagner AK, et al. 2017. Nat Commun. 8:15627. PubMed
  179. Yamasaki T, et al. 2018. J Virol. 92:e01458. PubMed
  180. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  181. Nicolas-Boluda A, et al. 2021. eLife. 10:00. PubMed
  182. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  183. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  184. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  185. Stotesbury C, et al. 2020. Aging Cell. 19:e13170. PubMed
  186. Wen J, et al. 2021. PLoS Pathog. 17:e1009738. PubMed
  187. Murenu E, et al. 2021. Mol Ther Methods Clin Dev. 20:587. PubMed
  188. Murenu E, et al. 2021. Int J Mol Sci. 22:. PubMed
  189. Karuppuchamy T, et al. 2020. Inflamm Bowel Dis. 216:26. PubMed
  190. Aikawa S, et al. 2020. Cell Death Differ. 1489:27. PubMed
  191. Heib T, et al. 2021. Cell Reports. 35(6):109102. PubMed
  192. Chevrier S, et al. 2021. Cell Reports Medicine. 2(1):100166. PubMed
  193. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  194. Sun Y, et al. 2015. Proc Natl Acad Sci U S A. 112: 10401-10406. PubMed
  195. Olver S, et al. 2005. Cancer Res. 66:571. PubMed
  196. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  197. Andrews AR, et al. 2019. Cancer Cell Int. 0.955555556. PubMed
  198. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  199. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  200. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  201. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  202. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  203. Chevrier S, et al. 2018. Cell Syst. 0.675. PubMed
  204. Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
  205. Larson–Casey JL, et al. 2019. J Clin Invest. 129:4962. PubMed
  206. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  207. Hsieh YL, et al. 2019. Cell Reports. 29(8):2134-2143.e7. PubMed
  208. Zheng C, et al. 2021. J Extracell Vesicles. 10:e12109. PubMed
  209. Song M, et al. 2020. Nat Commun. 11:6298. PubMed
  210. Dubik M, et al. 2021. Front Neurosci. 15:682451. PubMed
  211. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  212. Flores I, et al. 2021. Hum Mol Genet. Online ahead of print. PubMed
  213. Li Y, et al. 2021. Life Sci Alliance. 4:. PubMed
  214. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  215. Li X, et al. 2020. J Clin Invest. 130:4182. PubMed
  216. Kang SH, et al. 2018. Oncoimmunology. 8:e1515057. PubMed
  217. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  218. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
  219. Ito Y, et al. 2018. J Exp Med. 215:2617. PubMed
  220. Regan–Komito D, et al. 2017. Front Immunol. 1.459027778. PubMed
  221. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  222. Torika N, et al. 2018. CNS Neurosci Ther. 24:231. PubMed
  223. Zhou N et al. 2018. Protein & cell. 10(2):87-103 . PubMed
  224. Peterson EJ, et al. 2019. Mol Syst Biol. 15:e8584. PubMed
  225. Axelrod HD, et al. 2019. Mol Cancer Res. 17:356. PubMed
  226. Tong CF, et al. 2018. Am J Physiol Cell Physiol. 315:C409. PubMed
  227. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  228. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  229. Taki M, et al. 2018. Nat Commun. 1.545138889. PubMed
  230. Vinaik R, et al. 2019. Am J Physiol Endocrinol Metab. 317:E751. PubMed
  231. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  232. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  233. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  234. Li F, et al. 2020. EMBO J. 39:e103205. PubMed
  235. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  236. Doll JR, et al. 2020. PLoS Pathog. 16:e1008296. PubMed
  237. Yu H, et al. 2020. Front Immunol. 11:1773. PubMed
  238. Cai S, et al. 2020. Sci Rep. 10:14249. PubMed
  239. Calcagno DM, et al. 2020. Sci Immunol. 5: . PubMed
  240. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  241. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  242. Moore J, et al. 2022. Cancer Res. 82:365. PubMed
  243. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  244. Xiong T, et al. 2022. Cancer Sci. 113:1955. PubMed
  245. Campisi L, et al. 2022. Nature. 606:945. PubMed
  246. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  247. Zhao J, et al. 2022. J Clin Invest. 132: . PubMed
  248. Gavish A, et al. 2023. iScience. 26:105826. PubMed
  249. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  250. Potempa M, et al. 2022. J Immunol. 208:1742. PubMed
  251. Shirai T, et al. 2022. Cancer Sci. 113:3710. PubMed
  252. Chen W, et al. 2023. JCI Insight. 8:. PubMed
  253. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  254. Kang YA, et al. 2023. J Exp Med. 220:. PubMed
  255. Diray-Arce J, et al. 2023. Cell Rep Med. 4:101079. PubMed
  256. Yonemitsu K, et al. 2022. Sci Rep. 12:12007. PubMed
  257. Pilling D, et al. 2022. Respir Res. 23:215. PubMed
  258. Bajaña S, et al. 2021. Front Immunol. 11:577718. PubMed
  259. Zhao J, et al. 2021. JCI Insight. 6:. PubMed
  260. Larson-Casey JL, et al. 2021. FASEB J. 35:e21675. PubMed
  261. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  262. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  263. Weidner H, et al. 2020. JCI Insight. 5:00. PubMed
  264. Kim D, et al. 2008. Blood. 112:1109. PubMed
  265. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  266. Chung MI, et al. 2018. Am J Respir Cell Mol Biol. 59:706. PubMed
  267. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  268. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  269. Shirakawa K, et al. 2017. PLoS One. 12:e0186303. PubMed
  270. Zhou LJ et al. 2019. Cell Rep. 27(13):3844-3859 . PubMed
  271. Bachran C, et al. 2017. Sci Rep.. 10.1038/s41598-017-17948-0. PubMed
  272. Wagner J et al. 2019. Cell. 177(5):1330-1345 . PubMed
  273. Peng J, et al. 2019. Mol Brain. 12:71. PubMed
  274. Ajona D, et al. 2017. Cancer Discov. 0.773611111. PubMed
  275. Goel S, et al. 2017. Nature. 548:471. PubMed
  276. Tang B, et al. 2019. Oncolytic Virother. 8:03. PubMed
  277. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  278. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  279. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  280. Leyva-Castillo JM, et al. 2020. Clin Immunol. 218:108511. PubMed
  281. Dertschnig S, et al. 2020. J Clin Invest. 130:1896. PubMed
  282. Dienz O, et al. 2020. J Immunol. 204:1521. PubMed
  283. Nguyen N, et al. 2022. iScience. 25:103679. PubMed
  284. Karhadkar TR, et al. 2021. J Pharmacol Exp Ther. 376:106. PubMed
  285. Rogic A, et al. 2021. Nat Commun. 12:6889. PubMed
  286. Chen L, et al. 2019. Nat Commun. 3.553472222. PubMed
  287. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  288. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  289. Dave K et al. 2017. eLife. 6 pii: e23382. PubMed
  290. Arimura K, et al. 2017. Mucosal Immunol. 1.08125. PubMed
  291. Liu T, et al. 2020. Sci Adv. 6:eaay1497. PubMed
  292. Peng J, et al. 2016. Nat Commun. 7:12029. PubMed
  293. Bredehöft J, et al. 2022. J Inflamm Res. 15:509. PubMed
  294. Tian D, et al. 2020. FASEB J. 34:3367. PubMed
  295. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  296. Lee JH, et al. 2022. iScience. 25:104166. PubMed
  297. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  298. Tal MC, et al. 2020. MBio. 11:00. PubMed
  299. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  300. Haney MS, et al. 2018. Nat Genet. 50:1716. PubMed
  301. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  302. Rissiek B, et al. 2017. Sci Rep. . 10.1038/s41598-017-16613-w. PubMed
  303. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  304. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  305. Yang C, et al. 2019. MBio. 10:e00595-19. PubMed
  306. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  307. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  308. Guiducci E, et al. 2018. Front Immunol. 1.467361111. PubMed
  309. Guo Y, et al. 2008. Blood. 112:480. PubMed
  310. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  311. Si Y, et al. 2020. Sci Adv. 6:eaaw7713. PubMed
  312. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  313. Matsuhira T, et al. 2021. Biochem Biophys Rep. 28:101118. PubMed
  314. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  315. Yan J, et al. 2020. Cancer Immunol Res. 8:356. PubMed
  316. Gomi M, et al. 2021. Mol Ther. 29:225. PubMed
  317. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
  318. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  319. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  320. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  321. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  322. Zhao L, et al. 2018. Nat Med. 24:1536. PubMed
  323. Manni M, et al. 2018. Nat Immunol. 1.074305556. PubMed
  324. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  325. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  326. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  327. Napimoga M, et al. 2008. J Immunol. 180:609. PubMed
  328. Francis M, et al. 2017. Toxicol Sci. 155(1):182-195. PubMed
  329. Lai JF, et al. 2020. J Allergy Clin Immunol. 146:1406. PubMed
  330. Vukman KV, et al. 2020. J Extracell Vesicles. 10:e12023. PubMed
  331. Jiang L, et al. 2022. Front Immunol. 12:730438. PubMed
  332. Sato Y, et al. 2021. BMC Cancer. 21:1222. PubMed
  333. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  334. Muraleedharan A, et al. 2021. Glia. 69:697. PubMed
  335. Bednarczyk M, et al. 2021. Int J Mol Sci. 22:. PubMed
  336. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  337. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  338. Hakamivala A, et al. 2020. Bioact Mater. 5:142. PubMed
  339. Zhong X, et al. 2020. Proc Natl Acad Sci U S A. 8563:117. PubMed
  340. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  341. Wei S, et al. 2019. Virulence. 0.588888889. PubMed
  342. Kapellos TS, et al. 2017. Mediators Inflamm. 2017:4315412. PubMed
  343. Umemoto T, et al. 2017. EMBO J. 36:2390. PubMed
  344. Kim SJ, et al. 2017. Nat Immunol. 18:1016. PubMed
  345. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  346. Wicki S, et al. 2018. Int J Mol Sci. 1.266666667. PubMed
  347. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  348. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  349. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  350. Paharik AE, et al. 2017. Cell Host Microbe. 22:746. PubMed
  351. Nascimento DC, et al. 2017. Nat Commun. 8:14919. PubMed
  352. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  353. Majer O, et al. 2019. Nature. 575:366. PubMed
  354. Coden ME, et al. 2020. J Immunol. 204:438. PubMed
  355. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  356. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  357. Manabe T, et al. 2021. J Neurochem. 159:525. PubMed
  358. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  359. Lim CS, et al. 2020. Front Immunol. 11:1186. PubMed
  360. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  361. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  362. You X, et al. 2022. Front Genet. 12:790990. PubMed
  363. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  364. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  365. Huang S, et al. 2020. Cell Rep. 33:108394. PubMed
  366. Daley D, et al. 2017. Nat Med. 23:556. PubMed
  367. Hsieh JY, et al. 2019. APL Bioeng. 3:016103. PubMed
  368. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  369. Madsen D, et al. 2017. Cell Rep.. 10.1016/j.celrep.2017.12.011. PubMed
  370. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  371. Yoon BH, et al. 2018. Mol Cells. 41:953. PubMed
  372. Hoffmann FM, et al. 2018. Front Immunol. 9:1046. PubMed
  373. Baumgartner C, et al. 2010. J Immunol. 184:573. PubMed
  374. Yi MH, et al. 2020. Brain Behav Immun. 92:78. PubMed
  375. Meyer-Lindemann U, et al. 2022. Front Immunol. 13:898690. PubMed
  376. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  377. Li J, et al. 2021. Front Immunol. 12:710406. PubMed
  378. Nguyen CH, et al. 2020. Biomedicines. 8:. PubMed
  379. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  380. Speir M, et al. 2020. Nat Immunol. 21:54. PubMed
  381. Kikuchi A, et al. 2020. Am J Pathol. 190:2080. PubMed
  382. Freeman SA, et al. 2020. Science. 367:301. PubMed
  383. Galbas T, et al. 2017. J Immunol. 198(2):852-861. PubMed
  384. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  385. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  386. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  387. Wang Y, et al. 2019. Biomed Res Int. 2019:5756189. PubMed
  388. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  389. Elgazar-Carmon V, et al. 2008. J Lipid Res. 49:1849. PubMed
  390. Ding L, et al. 2022. Nanoscale. . PubMed
  391. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  392. Vahsen BF, et al. 2022. Sci Rep. 12:12606. PubMed
  393. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  394. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  395. Wu W, et al. 2020. Brain Behav Immun. 89:245. PubMed
  396. Qiu Z, et al. 2022. Cancer Discov. 12:502. PubMed
  397. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  398. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  399. Takeuchi Y, et al. 2021. Sci Rep. 11:18679. PubMed
  400. Feng L, et al. 2019. Glia. 67:1434. PubMed
  401. Wagner AK, et al. 2017. Nat Commun. 8:15627. PubMed
  402. Yamasaki T, et al. 2018. J Virol. 92:e01458. PubMed
  403. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  404. Nicolas-Boluda A, et al. 2021. eLife. 10:00. PubMed
  405. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  406. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  407. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  408. Stotesbury C, et al. 2020. Aging Cell. 19:e13170. PubMed
  409. Wen J, et al. 2021. PLoS Pathog. 17:e1009738. PubMed
  410. Murenu E, et al. 2021. Mol Ther Methods Clin Dev. 20:587. PubMed
  411. Murenu E, et al. 2021. Int J Mol Sci. 22:. PubMed
  412. Karuppuchamy T, et al. 2020. Inflamm Bowel Dis. 216:26. PubMed
  413. Aikawa S, et al. 2020. Cell Death Differ. 1489:27. PubMed
  414. Heib T, et al. 2021. Cell Reports. 35(6):109102. PubMed
  415. Chevrier S, et al. 2021. Cell Reports Medicine. 2(1):100166. PubMed
  416. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  417. Sun Y, et al. 2015. Proc Natl Acad Sci U S A. 112: 10401-10406. PubMed
  418. Olver S, et al. 2005. Cancer Res. 66:571. PubMed
  419. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  420. Andrews AR, et al. 2019. Cancer Cell Int. 0.955555556. PubMed
  421. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  422. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  423. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  424. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  425. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  426. Chevrier S, et al. 2018. Cell Syst. 0.675. PubMed
  427. Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
  428. Larson–Casey JL, et al. 2019. J Clin Invest. 129:4962. PubMed
  429. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  430. Hsieh YL, et al. 2019. Cell Reports. 29(8):2134-2143.e7. PubMed
  431. Zheng C, et al. 2021. J Extracell Vesicles. 10:e12109. PubMed
  432. Song M, et al. 2020. Nat Commun. 11:6298. PubMed
  433. Dubik M, et al. 2021. Front Neurosci. 15:682451. PubMed
  434. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  435. Flores I, et al. 2021. Hum Mol Genet. Online ahead of print. PubMed
  436. Li Y, et al. 2021. Life Sci Alliance. 4:. PubMed
  437. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  438. Li X, et al. 2020. J Clin Invest. 130:4182. PubMed
  439. Kang SH, et al. 2018. Oncoimmunology. 8:e1515057. PubMed
  440. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  441. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
  442. Ito Y, et al. 2018. J Exp Med. 215:2617. PubMed
  443. Regan–Komito D, et al. 2017. Front Immunol. 1.459027778. PubMed
  444. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  445. Torika N, et al. 2018. CNS Neurosci Ther. 24:231. PubMed
  446. Zhou N et al. 2018. Protein & cell. 10(2):87-103 . PubMed
RRID
AB_312784 (BioLegend Cat. No. 101201)
AB_312785 (BioLegend Cat. No. 101202)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS B550™ anti-mouse/human CD11b M1/70 FC
Spark YG™ 581 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS V475™ anti-mouse/human CD11b M1/70 FC
StarBright UltraViolet 575 anti-mouse/human CD11b M1/70 FC
StarBright UltraViolet 740 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 4    Revision Date: 12/13/2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
1-M1slash70_Purified_042706
C57BL/6 mouse bone marrow cells were stained with purified CD11b (clone M1/70) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by anti-rat IgG FITC (gated on total cells).
  • 1-M1slash70_Purified_042706
    C57BL/6 mouse bone marrow cells were stained with purified CD11b (clone M1/70) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by anti-rat IgG FITC (gated on total cells).
  • 2-M170_Pure_CD11b_Antibody_IHC_102418
    Fresh, frozen mouse spleen was stained with purified CD11b clone M1/70 conjugated and detected with a Cy5 CODEX™ oligonucleotide duplex (red). Samples were counterstained with TCR FITC (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Compare all formats
Cat # Size Price Quantity Check Availability Save
101201 50 µg DKK179
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101202 500 µg DKK678
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F, CyTOF® - Verified
IP, ICC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Peterson EJ, et al. 2019. Mol Syst Biol. 15:e8584. PubMed
  2. Axelrod HD, et al. 2019. Mol Cancer Res. 17:356. PubMed
  3. Tong CF, et al. 2018. Am J Physiol Cell Physiol. 315:C409. PubMed
  4. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  5. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  6. Taki M, et al. 2018. Nat Commun. 1.545138889. PubMed
  7. Vinaik R, et al. 2019. Am J Physiol Endocrinol Metab. 317:E751. PubMed
  8. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  9. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  10. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  11. Li F, et al. 2020. EMBO J. 39:e103205. PubMed
  12. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  13. Doll JR, et al. 2020. PLoS Pathog. 16:e1008296. PubMed
  14. Yu H, et al. 2020. Front Immunol. 11:1773. PubMed
  15. Cai S, et al. 2020. Sci Rep. 10:14249. PubMed
  16. Calcagno DM, et al. 2020. Sci Immunol. 5: . PubMed
  17. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  18. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  19. Moore J, et al. 2022. Cancer Res. 82:365. PubMed
  20. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  21. Xiong T, et al. 2022. Cancer Sci. 113:1955. PubMed
  22. Campisi L, et al. 2022. Nature. 606:945. PubMed
  23. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  24. Zhao J, et al. 2022. J Clin Invest. 132: . PubMed
  25. Gavish A, et al. 2023. iScience. 26:105826. PubMed
  26. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  27. Potempa M, et al. 2022. J Immunol. 208:1742. PubMed
  28. Shirai T, et al. 2022. Cancer Sci. 113:3710. PubMed
  29. Chen W, et al. 2023. JCI Insight. 8:. PubMed
  30. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  31. Kang YA, et al. 2023. J Exp Med. 220:. PubMed
  32. Diray-Arce J, et al. 2023. Cell Rep Med. 4:101079. PubMed
  33. Yonemitsu K, et al. 2022. Sci Rep. 12:12007. PubMed
  34. Pilling D, et al. 2022. Respir Res. 23:215. PubMed
  35. Bajaña S, et al. 2021. Front Immunol. 11:577718. PubMed
  36. Zhao J, et al. 2021. JCI Insight. 6:. PubMed
  37. Larson-Casey JL, et al. 2021. FASEB J. 35:e21675. PubMed
  38. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  39. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  40. Weidner H, et al. 2020. JCI Insight. 5:00. PubMed
  41. Kim D, et al. 2008. Blood. 112:1109. PubMed
  42. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  43. Chung MI, et al. 2018. Am J Respir Cell Mol Biol. 59:706. PubMed
  44. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  45. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  46. Shirakawa K, et al. 2017. PLoS One. 12:e0186303. PubMed
  47. Zhou LJ et al. 2019. Cell Rep. 27(13):3844-3859 . PubMed
  48. Bachran C, et al. 2017. Sci Rep.. 10.1038/s41598-017-17948-0. PubMed
  49. Wagner J et al. 2019. Cell. 177(5):1330-1345 . PubMed
  50. Peng J, et al. 2019. Mol Brain. 12:71. PubMed
  51. Ajona D, et al. 2017. Cancer Discov. 0.773611111. PubMed
  52. Goel S, et al. 2017. Nature. 548:471. PubMed
  53. Tang B, et al. 2019. Oncolytic Virother. 8:03. PubMed
  54. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  55. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  56. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  57. Leyva-Castillo JM, et al. 2020. Clin Immunol. 218:108511. PubMed
  58. Dertschnig S, et al. 2020. J Clin Invest. 130:1896. PubMed
  59. Dienz O, et al. 2020. J Immunol. 204:1521. PubMed
  60. Nguyen N, et al. 2022. iScience. 25:103679. PubMed
  61. Karhadkar TR, et al. 2021. J Pharmacol Exp Ther. 376:106. PubMed
  62. Rogic A, et al. 2021. Nat Commun. 12:6889. PubMed
  63. Chen L, et al. 2019. Nat Commun. 3.553472222. PubMed
  64. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  65. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  66. Dave K et al. 2017. eLife. 6 pii: e23382. PubMed
  67. Arimura K, et al. 2017. Mucosal Immunol. 1.08125. PubMed
  68. Liu T, et al. 2020. Sci Adv. 6:eaay1497. PubMed
  69. Peng J, et al. 2016. Nat Commun. 7:12029. PubMed
  70. Bredehöft J, et al. 2022. J Inflamm Res. 15:509. PubMed
  71. Tian D, et al. 2020. FASEB J. 34:3367. PubMed
  72. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  73. Lee JH, et al. 2022. iScience. 25:104166. PubMed
  74. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  75. Tal MC, et al. 2020. MBio. 11:00. PubMed
  76. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  77. Haney MS, et al. 2018. Nat Genet. 50:1716. PubMed
  78. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  79. Rissiek B, et al. 2017. Sci Rep. . 10.1038/s41598-017-16613-w. PubMed
  80. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  81. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  82. Yang C, et al. 2019. MBio. 10:e00595-19. PubMed
  83. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  84. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  85. Guiducci E, et al. 2018. Front Immunol. 1.467361111. PubMed
  86. Guo Y, et al. 2008. Blood. 112:480. PubMed
  87. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  88. Si Y, et al. 2020. Sci Adv. 6:eaaw7713. PubMed
  89. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  90. Matsuhira T, et al. 2021. Biochem Biophys Rep. 28:101118. PubMed
  91. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  92. Yan J, et al. 2020. Cancer Immunol Res. 8:356. PubMed
  93. Gomi M, et al. 2021. Mol Ther. 29:225. PubMed
  94. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
  95. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  96. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  97. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  98. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  99. Zhao L, et al. 2018. Nat Med. 24:1536. PubMed
  100. Manni M, et al. 2018. Nat Immunol. 1.074305556. PubMed
  101. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  102. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  103. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  104. Napimoga M, et al. 2008. J Immunol. 180:609. PubMed
  105. Francis M, et al. 2017. Toxicol Sci. 155(1):182-195. PubMed
  106. Lai JF, et al. 2020. J Allergy Clin Immunol. 146:1406. PubMed
  107. Vukman KV, et al. 2020. J Extracell Vesicles. 10:e12023. PubMed
  108. Jiang L, et al. 2022. Front Immunol. 12:730438. PubMed
  109. Sato Y, et al. 2021. BMC Cancer. 21:1222. PubMed
  110. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  111. Muraleedharan A, et al. 2021. Glia. 69:697. PubMed
  112. Bednarczyk M, et al. 2021. Int J Mol Sci. 22:. PubMed
  113. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  114. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  115. Hakamivala A, et al. 2020. Bioact Mater. 5:142. PubMed
  116. Zhong X, et al. 2020. Proc Natl Acad Sci U S A. 8563:117. PubMed
  117. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  118. Wei S, et al. 2019. Virulence. 0.588888889. PubMed
  119. Kapellos TS, et al. 2017. Mediators Inflamm. 2017:4315412. PubMed
  120. Umemoto T, et al. 2017. EMBO J. 36:2390. PubMed
  121. Kim SJ, et al. 2017. Nat Immunol. 18:1016. PubMed
  122. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  123. Wicki S, et al. 2018. Int J Mol Sci. 1.266666667. PubMed
  124. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  125. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  126. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  127. Paharik AE, et al. 2017. Cell Host Microbe. 22:746. PubMed
  128. Nascimento DC, et al. 2017. Nat Commun. 8:14919. PubMed
  129. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  130. Majer O, et al. 2019. Nature. 575:366. PubMed
  131. Coden ME, et al. 2020. J Immunol. 204:438. PubMed
  132. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  133. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  134. Manabe T, et al. 2021. J Neurochem. 159:525. PubMed
  135. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  136. Lim CS, et al. 2020. Front Immunol. 11:1186. PubMed
  137. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  138. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  139. You X, et al. 2022. Front Genet. 12:790990. PubMed
  140. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  141. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  142. Huang S, et al. 2020. Cell Rep. 33:108394. PubMed
  143. Daley D, et al. 2017. Nat Med. 23:556. PubMed
  144. Hsieh JY, et al. 2019. APL Bioeng. 3:016103. PubMed
  145. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  146. Madsen D, et al. 2017. Cell Rep.. 10.1016/j.celrep.2017.12.011. PubMed
  147. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  148. Yoon BH, et al. 2018. Mol Cells. 41:953. PubMed
  149. Hoffmann FM, et al. 2018. Front Immunol. 9:1046. PubMed
  150. Baumgartner C, et al. 2010. J Immunol. 184:573. PubMed
  151. Yi MH, et al. 2020. Brain Behav Immun. 92:78. PubMed
  152. Meyer-Lindemann U, et al. 2022. Front Immunol. 13:898690. PubMed
  153. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  154. Li J, et al. 2021. Front Immunol. 12:710406. PubMed
  155. Nguyen CH, et al. 2020. Biomedicines. 8:. PubMed
  156. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  157. Speir M, et al. 2020. Nat Immunol. 21:54. PubMed
  158. Kikuchi A, et al. 2020. Am J Pathol. 190:2080. PubMed
  159. Freeman SA, et al. 2020. Science. 367:301. PubMed
  160. Galbas T, et al. 2017. J Immunol. 198(2):852-861. PubMed
  161. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  162. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  163. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  164. Wang Y, et al. 2019. Biomed Res Int. 2019:5756189. PubMed
  165. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  166. Elgazar-Carmon V, et al. 2008. J Lipid Res. 49:1849. PubMed
  167. Ding L, et al. 2022. Nanoscale. . PubMed
  168. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  169. Vahsen BF, et al. 2022. Sci Rep. 12:12606. PubMed
  170. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  171. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  172. Wu W, et al. 2020. Brain Behav Immun. 89:245. PubMed
  173. Qiu Z, et al. 2022. Cancer Discov. 12:502. PubMed
  174. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  175. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  176. Takeuchi Y, et al. 2021. Sci Rep. 11:18679. PubMed
  177. Feng L, et al. 2019. Glia. 67:1434. PubMed
  178. Wagner AK, et al. 2017. Nat Commun. 8:15627. PubMed
  179. Yamasaki T, et al. 2018. J Virol. 92:e01458. PubMed
  180. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  181. Nicolas-Boluda A, et al. 2021. eLife. 10:00. PubMed
  182. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  183. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  184. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  185. Stotesbury C, et al. 2020. Aging Cell. 19:e13170. PubMed
  186. Wen J, et al. 2021. PLoS Pathog. 17:e1009738. PubMed
  187. Murenu E, et al. 2021. Mol Ther Methods Clin Dev. 20:587. PubMed
  188. Murenu E, et al. 2021. Int J Mol Sci. 22:. PubMed
  189. Karuppuchamy T, et al. 2020. Inflamm Bowel Dis. 216:26. PubMed
  190. Aikawa S, et al. 2020. Cell Death Differ. 1489:27. PubMed
  191. Heib T, et al. 2021. Cell Reports. 35(6):109102. PubMed
  192. Chevrier S, et al. 2021. Cell Reports Medicine. 2(1):100166. PubMed
  193. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  194. Sun Y, et al. 2015. Proc Natl Acad Sci U S A. 112: 10401-10406. PubMed
  195. Olver S, et al. 2005. Cancer Res. 66:571. PubMed
  196. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  197. Andrews AR, et al. 2019. Cancer Cell Int. 0.955555556. PubMed
  198. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  199. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  200. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  201. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  202. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  203. Chevrier S, et al. 2018. Cell Syst. 0.675. PubMed
  204. Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
  205. Larson–Casey JL, et al. 2019. J Clin Invest. 129:4962. PubMed
  206. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  207. Hsieh YL, et al. 2019. Cell Reports. 29(8):2134-2143.e7. PubMed
  208. Zheng C, et al. 2021. J Extracell Vesicles. 10:e12109. PubMed
  209. Song M, et al. 2020. Nat Commun. 11:6298. PubMed
  210. Dubik M, et al. 2021. Front Neurosci. 15:682451. PubMed
  211. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  212. Flores I, et al. 2021. Hum Mol Genet. Online ahead of print. PubMed
  213. Li Y, et al. 2021. Life Sci Alliance. 4:. PubMed
  214. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  215. Li X, et al. 2020. J Clin Invest. 130:4182. PubMed
  216. Kang SH, et al. 2018. Oncoimmunology. 8:e1515057. PubMed
  217. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  218. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
  219. Ito Y, et al. 2018. J Exp Med. 215:2617. PubMed
  220. Regan–Komito D, et al. 2017. Front Immunol. 1.459027778. PubMed
  221. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  222. Torika N, et al. 2018. CNS Neurosci Ther. 24:231. PubMed
  223. Zhou N et al. 2018. Protein & cell. 10(2):87-103 . PubMed
  224. Peterson EJ, et al. 2019. Mol Syst Biol. 15:e8584. PubMed
  225. Axelrod HD, et al. 2019. Mol Cancer Res. 17:356. PubMed
  226. Tong CF, et al. 2018. Am J Physiol Cell Physiol. 315:C409. PubMed
  227. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  228. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  229. Taki M, et al. 2018. Nat Commun. 1.545138889. PubMed
  230. Vinaik R, et al. 2019. Am J Physiol Endocrinol Metab. 317:E751. PubMed
  231. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  232. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  233. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  234. Li F, et al. 2020. EMBO J. 39:e103205. PubMed
  235. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  236. Doll JR, et al. 2020. PLoS Pathog. 16:e1008296. PubMed
  237. Yu H, et al. 2020. Front Immunol. 11:1773. PubMed
  238. Cai S, et al. 2020. Sci Rep. 10:14249. PubMed
  239. Calcagno DM, et al. 2020. Sci Immunol. 5: . PubMed
  240. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  241. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  242. Moore J, et al. 2022. Cancer Res. 82:365. PubMed
  243. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  244. Xiong T, et al. 2022. Cancer Sci. 113:1955. PubMed
  245. Campisi L, et al. 2022. Nature. 606:945. PubMed
  246. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  247. Zhao J, et al. 2022. J Clin Invest. 132: . PubMed
  248. Gavish A, et al. 2023. iScience. 26:105826. PubMed
  249. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  250. Potempa M, et al. 2022. J Immunol. 208:1742. PubMed
  251. Shirai T, et al. 2022. Cancer Sci. 113:3710. PubMed
  252. Chen W, et al. 2023. JCI Insight. 8:. PubMed
  253. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  254. Kang YA, et al. 2023. J Exp Med. 220:. PubMed
  255. Diray-Arce J, et al. 2023. Cell Rep Med. 4:101079. PubMed
  256. Yonemitsu K, et al. 2022. Sci Rep. 12:12007. PubMed
  257. Pilling D, et al. 2022. Respir Res. 23:215. PubMed
  258. Bajaña S, et al. 2021. Front Immunol. 11:577718. PubMed
  259. Zhao J, et al. 2021. JCI Insight. 6:. PubMed
  260. Larson-Casey JL, et al. 2021. FASEB J. 35:e21675. PubMed
  261. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  262. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  263. Weidner H, et al. 2020. JCI Insight. 5:00. PubMed
  264. Kim D, et al. 2008. Blood. 112:1109. PubMed
  265. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  266. Chung MI, et al. 2018. Am J Respir Cell Mol Biol. 59:706. PubMed
  267. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  268. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  269. Shirakawa K, et al. 2017. PLoS One. 12:e0186303. PubMed
  270. Zhou LJ et al. 2019. Cell Rep. 27(13):3844-3859 . PubMed
  271. Bachran C, et al. 2017. Sci Rep.. 10.1038/s41598-017-17948-0. PubMed
  272. Wagner J et al. 2019. Cell. 177(5):1330-1345 . PubMed
  273. Peng J, et al. 2019. Mol Brain. 12:71. PubMed
  274. Ajona D, et al. 2017. Cancer Discov. 0.773611111. PubMed
  275. Goel S, et al. 2017. Nature. 548:471. PubMed
  276. Tang B, et al. 2019. Oncolytic Virother. 8:03. PubMed
  277. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  278. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  279. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  280. Leyva-Castillo JM, et al. 2020. Clin Immunol. 218:108511. PubMed
  281. Dertschnig S, et al. 2020. J Clin Invest. 130:1896. PubMed
  282. Dienz O, et al. 2020. J Immunol. 204:1521. PubMed
  283. Nguyen N, et al. 2022. iScience. 25:103679. PubMed
  284. Karhadkar TR, et al. 2021. J Pharmacol Exp Ther. 376:106. PubMed
  285. Rogic A, et al. 2021. Nat Commun. 12:6889. PubMed
  286. Chen L, et al. 2019. Nat Commun. 3.553472222. PubMed
  287. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  288. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  289. Dave K et al. 2017. eLife. 6 pii: e23382. PubMed
  290. Arimura K, et al. 2017. Mucosal Immunol. 1.08125. PubMed
  291. Liu T, et al. 2020. Sci Adv. 6:eaay1497. PubMed
  292. Peng J, et al. 2016. Nat Commun. 7:12029. PubMed
  293. Bredehöft J, et al. 2022. J Inflamm Res. 15:509. PubMed
  294. Tian D, et al. 2020. FASEB J. 34:3367. PubMed
  295. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  296. Lee JH, et al. 2022. iScience. 25:104166. PubMed
  297. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  298. Tal MC, et al. 2020. MBio. 11:00. PubMed
  299. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  300. Haney MS, et al. 2018. Nat Genet. 50:1716. PubMed
  301. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  302. Rissiek B, et al. 2017. Sci Rep. . 10.1038/s41598-017-16613-w. PubMed
  303. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  304. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  305. Yang C, et al. 2019. MBio. 10:e00595-19. PubMed
  306. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  307. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  308. Guiducci E, et al. 2018. Front Immunol. 1.467361111. PubMed
  309. Guo Y, et al. 2008. Blood. 112:480. PubMed
  310. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  311. Si Y, et al. 2020. Sci Adv. 6:eaaw7713. PubMed
  312. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  313. Matsuhira T, et al. 2021. Biochem Biophys Rep. 28:101118. PubMed
  314. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  315. Yan J, et al. 2020. Cancer Immunol Res. 8:356. PubMed
  316. Gomi M, et al. 2021. Mol Ther. 29:225. PubMed
  317. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
  318. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  319. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  320. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  321. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  322. Zhao L, et al. 2018. Nat Med. 24:1536. PubMed
  323. Manni M, et al. 2018. Nat Immunol. 1.074305556. PubMed
  324. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  325. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  326. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  327. Napimoga M, et al. 2008. J Immunol. 180:609. PubMed
  328. Francis M, et al. 2017. Toxicol Sci. 155(1):182-195. PubMed
  329. Lai JF, et al. 2020. J Allergy Clin Immunol. 146:1406. PubMed
  330. Vukman KV, et al. 2020. J Extracell Vesicles. 10:e12023. PubMed
  331. Jiang L, et al. 2022. Front Immunol. 12:730438. PubMed
  332. Sato Y, et al. 2021. BMC Cancer. 21:1222. PubMed
  333. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  334. Muraleedharan A, et al. 2021. Glia. 69:697. PubMed
  335. Bednarczyk M, et al. 2021. Int J Mol Sci. 22:. PubMed
  336. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  337. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  338. Hakamivala A, et al. 2020. Bioact Mater. 5:142. PubMed
  339. Zhong X, et al. 2020. Proc Natl Acad Sci U S A. 8563:117. PubMed
  340. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  341. Wei S, et al. 2019. Virulence. 0.588888889. PubMed
  342. Kapellos TS, et al. 2017. Mediators Inflamm. 2017:4315412. PubMed
  343. Umemoto T, et al. 2017. EMBO J. 36:2390. PubMed
  344. Kim SJ, et al. 2017. Nat Immunol. 18:1016. PubMed
  345. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  346. Wicki S, et al. 2018. Int J Mol Sci. 1.266666667. PubMed
  347. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  348. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  349. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  350. Paharik AE, et al. 2017. Cell Host Microbe. 22:746. PubMed
  351. Nascimento DC, et al. 2017. Nat Commun. 8:14919. PubMed
  352. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  353. Majer O, et al. 2019. Nature. 575:366. PubMed
  354. Coden ME, et al. 2020. J Immunol. 204:438. PubMed
  355. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  356. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  357. Manabe T, et al. 2021. J Neurochem. 159:525. PubMed
  358. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  359. Lim CS, et al. 2020. Front Immunol. 11:1186. PubMed
  360. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  361. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  362. You X, et al. 2022. Front Genet. 12:790990. PubMed
  363. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  364. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  365. Huang S, et al. 2020. Cell Rep. 33:108394. PubMed
  366. Daley D, et al. 2017. Nat Med. 23:556. PubMed
  367. Hsieh JY, et al. 2019. APL Bioeng. 3:016103. PubMed
  368. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  369. Madsen D, et al. 2017. Cell Rep.. 10.1016/j.celrep.2017.12.011. PubMed
  370. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  371. Yoon BH, et al. 2018. Mol Cells. 41:953. PubMed
  372. Hoffmann FM, et al. 2018. Front Immunol. 9:1046. PubMed
  373. Baumgartner C, et al. 2010. J Immunol. 184:573. PubMed
  374. Yi MH, et al. 2020. Brain Behav Immun. 92:78. PubMed
  375. Meyer-Lindemann U, et al. 2022. Front Immunol. 13:898690. PubMed
  376. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  377. Li J, et al. 2021. Front Immunol. 12:710406. PubMed
  378. Nguyen CH, et al. 2020. Biomedicines. 8:. PubMed
  379. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  380. Speir M, et al. 2020. Nat Immunol. 21:54. PubMed
  381. Kikuchi A, et al. 2020. Am J Pathol. 190:2080. PubMed
  382. Freeman SA, et al. 2020. Science. 367:301. PubMed
  383. Galbas T, et al. 2017. J Immunol. 198(2):852-861. PubMed
  384. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  385. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  386. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  387. Wang Y, et al. 2019. Biomed Res Int. 2019:5756189. PubMed
  388. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  389. Elgazar-Carmon V, et al. 2008. J Lipid Res. 49:1849. PubMed
  390. Ding L, et al. 2022. Nanoscale. . PubMed
  391. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  392. Vahsen BF, et al. 2022. Sci Rep. 12:12606. PubMed
  393. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  394. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  395. Wu W, et al. 2020. Brain Behav Immun. 89:245. PubMed
  396. Qiu Z, et al. 2022. Cancer Discov. 12:502. PubMed
  397. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  398. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  399. Takeuchi Y, et al. 2021. Sci Rep. 11:18679. PubMed
  400. Feng L, et al. 2019. Glia. 67:1434. PubMed
  401. Wagner AK, et al. 2017. Nat Commun. 8:15627. PubMed
  402. Yamasaki T, et al. 2018. J Virol. 92:e01458. PubMed
  403. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  404. Nicolas-Boluda A, et al. 2021. eLife. 10:00. PubMed
  405. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  406. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  407. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  408. Stotesbury C, et al. 2020. Aging Cell. 19:e13170. PubMed
  409. Wen J, et al. 2021. PLoS Pathog. 17:e1009738. PubMed
  410. Murenu E, et al. 2021. Mol Ther Methods Clin Dev. 20:587. PubMed
  411. Murenu E, et al. 2021. Int J Mol Sci. 22:. PubMed
  412. Karuppuchamy T, et al. 2020. Inflamm Bowel Dis. 216:26. PubMed
  413. Aikawa S, et al. 2020. Cell Death Differ. 1489:27. PubMed
  414. Heib T, et al. 2021. Cell Reports. 35(6):109102. PubMed
  415. Chevrier S, et al. 2021. Cell Reports Medicine. 2(1):100166. PubMed
  416. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  417. Sun Y, et al. 2015. Proc Natl Acad Sci U S A. 112: 10401-10406. PubMed
  418. Olver S, et al. 2005. Cancer Res. 66:571. PubMed
  419. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  420. Andrews AR, et al. 2019. Cancer Cell Int. 0.955555556. PubMed
  421. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  422. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  423. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  424. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  425. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  426. Chevrier S, et al. 2018. Cell Syst. 0.675. PubMed
  427. Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
  428. Larson–Casey JL, et al. 2019. J Clin Invest. 129:4962. PubMed
  429. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  430. Hsieh YL, et al. 2019. Cell Reports. 29(8):2134-2143.e7. PubMed
  431. Zheng C, et al. 2021. J Extracell Vesicles. 10:e12109. PubMed
  432. Song M, et al. 2020. Nat Commun. 11:6298. PubMed
  433. Dubik M, et al. 2021. Front Neurosci. 15:682451. PubMed
  434. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  435. Flores I, et al. 2021. Hum Mol Genet. Online ahead of print. PubMed
  436. Li Y, et al. 2021. Life Sci Alliance. 4:. PubMed
  437. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  438. Li X, et al. 2020. J Clin Invest. 130:4182. PubMed
  439. Kang SH, et al. 2018. Oncoimmunology. 8:e1515057. PubMed
  440. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  441. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
  442. Ito Y, et al. 2018. J Exp Med. 215:2617. PubMed
  443. Regan–Komito D, et al. 2017. Front Immunol. 1.459027778. PubMed
  444. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  445. Torika N, et al. 2018. CNS Neurosci Ther. 24:231. PubMed
  446. Zhou N et al. 2018. Protein & cell. 10(2):87-103 . PubMed
RRID
AB_312784 (BioLegend Cat. No. 101201)
AB_312785 (BioLegend Cat. No. 101202)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS B550™ anti-mouse/human CD11b M1/70 FC
Spark YG™ 581 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS V475™ anti-mouse/human CD11b M1/70 FC
StarBright UltraViolet 575 anti-mouse/human CD11b M1/70 FC
StarBright UltraViolet 740 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 4    Revision Date: 12/13/2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account